BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 30266663)

  • 1. Sarcopenia and sarcopenic obesity are significantly associated with poorer overall survival in patients with pancreatic cancer: Systematic review and meta-analysis.
    Mintziras I; Miligkos M; Wächter S; Manoharan J; Maurer E; Bartsch DK
    Int J Surg; 2018 Nov; 59():19-26. PubMed ID: 30266663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sarcopenia and sarcopenic obesity are independent adverse prognostic factors in resectable pancreatic ductal adenocarcinoma.
    Gruber ES; Jomrich G; Tamandl D; Gnant M; Schindl M; Sahora K
    PLoS One; 2019; 14(5):e0215915. PubMed ID: 31059520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of cachexia and sarcopenia on survival in pancreatic ductal adenocarcinoma: a systematic review.
    Ozola Zalite I; Zykus R; Francisco Gonzalez M; Saygili F; Pukitis A; Gaujoux S; Charnley RM; Lyadov V
    Pancreatology; 2015; 15(1):19-24. PubMed ID: 25524484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations of body composition parameters with postoperative outcome and perineural tumour invasion after oncological pancreatic resection.
    Mueller TC; Henselmann M; Reischl S; Jaeger C; Trefzer C; Demir IE; Friess H; Martignoni ME
    BMC Surg; 2024 Jun; 24(1):175. PubMed ID: 38835067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Body composition measurements and clinical outcomes in patients with resectable pancreatic adenocarcinoma - analysis from SWOG S1505.
    Sohal DPS; Boutin RD; Lenchik L; Kim J; Beg MS; Wang-Gillam A; Wade JL; Guthrie KA; Chiorean EG; Ahmad SA; Lowy AM; Philip PA; Chang VT
    J Gastrointest Surg; 2024 Mar; 28(3):232-235. PubMed ID: 38445914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of preoperative CT scan derived body composition measures in resected pancreatic cancer.
    Guarneri G; Pecorelli N; Bettinelli A; Campisi A; Palumbo D; Genova L; Gasparini G; Provinciali L; Della Corte A; Abati M; Aleotti F; Crippa S; De Cobelli F; Falconi M
    Eur J Surg Oncol; 2024 May; 50(5):106848. PubMed ID: 36863915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of preoperative sarcopenia in predicting postoperative complications and survival after pancreatoduodenectomy for pancreatic cancer.
    La Vaccara V; Cascone C; Coppola A; Farolfi T; Cammarata R; Emerenziani S; Coppola R; Caputo D
    Ann Ital Chir; 2023; 94():45-51. PubMed ID: 36810297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sarcopenia is an Independent Prognostic Factor in Patients With Pancreatic Cancer - a Meta-analysis.
    Thormann M; Hinnerichs M; Barajas Ordonez F; Saalfeld S; Perrakis A; Croner R; Omari J; Pech M; Zamsheva M; Meyer HJ; Wienke A; Surov A
    Acad Radiol; 2023 Aug; 30(8):1552-1561. PubMed ID: 36564257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Sarcopenic Obesity on Failure to Rescue from Major Complications Following Pancreaticoduodenectomy for Cancer: Results from a Multicenter Study.
    Pecorelli N; Capretti G; Sandini M; Damascelli A; Cristel G; De Cobelli F; Gianotti L; Zerbi A; Braga M
    Ann Surg Oncol; 2018 Jan; 25(1):308-317. PubMed ID: 29116490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical impact of sarcopenia on prognosis in pancreatic ductal adenocarcinoma: A retrospective cohort study.
    Ninomiya G; Fujii T; Yamada S; Yabusaki N; Suzuki K; Iwata N; Kanda M; Hayashi M; Tanaka C; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
    Int J Surg; 2017 Mar; 39():45-51. PubMed ID: 28110029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are sarcopenia, obesity and sarcopenic obesity predictive of outcome in patients with colorectal liver metastases?
    Lodewick TM; van Nijnatten TJ; van Dam RM; van Mierlo K; Dello SA; Neumann UP; Olde Damink SW; Dejong CH
    HPB (Oxford); 2015 May; 17(5):438-46. PubMed ID: 25512239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact Total Psoas Volume on Short- and Long-Term Outcomes in Patients Undergoing Curative Resection for Pancreatic Adenocarcinoma: a New Tool to Assess Sarcopenia.
    Amini N; Spolverato G; Gupta R; Margonis GA; Kim Y; Wagner D; Rezaee N; Weiss MJ; Wolfgang CL; Makary MM; Kamel IR; Pawlik TM
    J Gastrointest Surg; 2015 Sep; 19(9):1593-602. PubMed ID: 25925237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postoperative morbidity following pancreatic cancer surgery is significantly associated with worse overall patient survival; systematic review and meta-analysis.
    Mintziras I; Wächter S; Manoharan J; Kanngiesser V; Maurer E; Bartsch DK
    Surg Oncol; 2021 Sep; 38():101573. PubMed ID: 33857838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sarcopenic Obesity Is Associated with Severe Postoperative Complications in Gastric Cancer Patients Undergoing Gastrectomy: a Prospective Study.
    Zhang WT; Lin J; Chen WS; Huang YS; Wu RS; Chen XD; Lou N; Chi CH; Hu CY; Shen X
    J Gastrointest Surg; 2018 Nov; 22(11):1861-1869. PubMed ID: 29943139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sarcopenic obesity and its association with respiratory disease incidence and mortality.
    Petermann-Rocha F; Yang S; Gray SR; Pell JP; Celis-Morales C; Ho FK
    Clin Nutr; 2020 Nov; 39(11):3461-3466. PubMed ID: 32204975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of sarcopenia and myosteatosis on outcomes of unresectable pancreatic cancer or distal cholangiocarcinoma.
    Rollins KE; Tewari N; Ackner A; Awwad A; Madhusudan S; Macdonald IA; Fearon KC; Lobo DN
    Clin Nutr; 2016 Oct; 35(5):1103-9. PubMed ID: 26411749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of sarcopenia and visceral obesity on mortality and pancreatic fistula following pancreatic cancer surgery.
    Pecorelli N; Carrara G; De Cobelli F; Cristel G; Damascelli A; Balzano G; Beretta L; Braga M
    Br J Surg; 2016 Mar; 103(4):434-42. PubMed ID: 26780231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive value of sarcopenia and visceral obesity for postoperative pancreatic fistula after pancreaticoduodenectomy analyzed on clinically acquired CT and MRI.
    Jang M; Park HW; Huh J; Lee JH; Jeong YK; Nah YW; Park J; Kim KW
    Eur Radiol; 2019 May; 29(5):2417-2425. PubMed ID: 30406311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative sarcopenia is associated with poor overall survival in pancreatic cancer patients following pancreaticoduodenectomy.
    Peng YC; Wu CH; Tien YW; Lu TP; Wang YH; Chen BB
    Eur Radiol; 2021 Apr; 31(4):2472-2481. PubMed ID: 32974690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of Visceral Obesity, Sarcopenia and Sarcopenic Obesity on Surgical Outcomes After Liver Resections for Colorectal Metastases.
    Runkel M; Diallo TD; Lang SA; Bamberg F; Benndorf M; Fichtner-Feigl S
    World J Surg; 2021 Jul; 45(7):2218-2226. PubMed ID: 33842995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.